These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24496081)

  • 1. Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors.
    Wu EJ; Goussetis DJ; Beauchamp E; Kosciuczuk EM; Altman JK; Eklund EA; Platanias LC
    Cancer Biol Ther; 2014 Apr; 15(4):473-8. PubMed ID: 24496081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR-ABL1-induced leukemogenesis and autophagic targeting by arsenic trioxide.
    Goussetis DJ; Gounaris E; Platanias LC
    Autophagy; 2013 Jan; 9(1):93-4. PubMed ID: 23051894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide.
    Goussetis DJ; Gounaris E; Wu EJ; Vakana E; Sharma B; Bogyo M; Altman JK; Platanias LC
    Blood; 2012 Oct; 120(17):3555-62. PubMed ID: 22898604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses.
    Altman JK; Yoon P; Katsoulidis E; Kroczynska B; Sassano A; Redig AJ; Glaser H; Jordan A; Tallman MS; Hay N; Platanias LC
    J Biol Chem; 2008 Jan; 283(4):1992-2001. PubMed ID: 18048359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide.
    Goussetis DJ; Altman JK; Glaser H; McNeer JL; Tallman MS; Platanias LC
    J Biol Chem; 2010 Sep; 285(39):29989-97. PubMed ID: 20656687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct binding of arsenic trioxide to AMPK and generation of inhibitory effects on acute myeloid leukemia precursors.
    Beauchamp EM; Kosciuczuk EM; Serrano R; Nanavati D; Swindell EP; Viollet B; O'Halloran TV; Altman JK; Platanias LC
    Mol Cancer Ther; 2015 Jan; 14(1):202-12. PubMed ID: 25344585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia.
    La Rosée P; Johnson K; O'Dwyer ME; Druker BJ
    Exp Hematol; 2002 Jul; 30(7):729-37. PubMed ID: 12135670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCR-ABL/p62/SQSTM1: a cannibal embrace.
    Auberger P
    Blood; 2012 Oct; 120(17):3389-90. PubMed ID: 23100300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis.
    Ye Y; Xu X; Zhang M; Qiu D; Bai X; Wang J; Weng G; Zhou R; Guo Z; He H; Yi W; He X; Guo K
    Leuk Lymphoma; 2015; 56(11):3159-67. PubMed ID: 25739941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
    Gu S; Chen C; Jiang X; Zhang Z
    Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the kinase RSK1 by arsenic trioxide and generation of antileukemic responses.
    Galvin JP; Altman JK; Szilard A; Goussetis DJ; Vakana E; Sassano A; Platanias LC
    Cancer Biol Ther; 2013 May; 14(5):411-6. PubMed ID: 23377826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting catalase but not peroxiredoxins enhances arsenic trioxide-induced apoptosis in K562 cells.
    Song LL; Tu YY; Xia L; Wang WW; Wei W; Ma CM; Wen DH; Lei H; Xu HZ; Wu YL
    PLoS One; 2014; 9(8):e104985. PubMed ID: 25115845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL-expressing cells.
    Yoon P; Giafis N; Smith J; Mears H; Katsoulidis E; Sassano A; Altman J; Redig AJ; Tallman MS; Platanias LC
    Mol Cancer Ther; 2006 Nov; 5(11):2815-23. PubMed ID: 17121928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L).
    Perkins C; Kim CN; Fang G; Bhalla KN
    Blood; 2000 Feb; 95(3):1014-22. PubMed ID: 10648417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide-dependent activation of thousand-and-one amino acid kinase 2 and transforming growth factor-beta-activated kinase 1.
    McNeer JL; Goussetis DJ; Sassano A; Dolniak B; Kroczynska B; Glaser H; Altman JK; Platanias LC
    Mol Pharmacol; 2010 May; 77(5):828-35. PubMed ID: 20159944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells.
    Zheng X; Seshire A; Rüster B; Bug G; Beissert T; Puccetti E; Hoelzer D; Henschler R; Ruthardt M
    Haematologica; 2007 Mar; 92(3):323-31. PubMed ID: 17339181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic disulfide synergizes with the phosphoinositide 3-kinase inhibitor PI-103 to eradicate acute myeloid leukemia stem cells by inducing differentiation.
    Hong Z; Xiao M; Yang Y; Han Z; Cao Y; Li C; Wu Y; Gong Q; Zhou X; Xu D; Meng L; Ma D; Zhou J
    Carcinogenesis; 2011 Oct; 32(10):1550-8. PubMed ID: 21803735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of small GTPase RalA regulates growth and arsenic-induced apoptosis in chronic myeloid leukemia (CML) cells.
    Zhu X; Li Y; Luo X; Fei J
    Cell Signal; 2012 Jun; 24(6):1134-40. PubMed ID: 22330069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal effect of arsenic sensitivity in human leukemia cell line K562 and K562/ADM using realgar transforming solution.
    Wang X; Zhang X; Xu Z; Wang Z; Yue X; Li H
    Biol Pharm Bull; 2013; 36(4):641-8. PubMed ID: 23358330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide.
    Verma A; Mohindru M; Deb DK; Sassano A; Kambhampati S; Ravandi F; Minucci S; Kalvakolanu DV; Platanias LC
    J Biol Chem; 2002 Nov; 277(47):44988-95. PubMed ID: 12239215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.